Savara Raises $149.5M to Advance Rare Lung Therapeutic Program
LANGHORNE, Pa., November 2, 2025 — Savara Inc. (Nasdaq: SVRA), a clinical-stage biopharmaceutical company specializing in rare respiratory diseases,...
GCP
Advertisement
PharmaDrug Restructures Debt to Strengthen Biopharma Pipeline
Toronto, Ontario – October 31, 2025 — PharmaDrug Inc. (CSE: PHRX; OTC Pink: LMLLF), a specialty pharmaceutical company focused...
Allosite Therapeutics Showcases Novel Integrin Therapies at ASN 2025
Miami, Florida – October 30, 2025 — Allosite Therapeutics, a biotechnology company pioneering allosteric integrin agonists for the treatment...
BBOT Showcases Novel RAS:PI3Kα Breaker at SABCS 2025
South San Francisco, Calif. – October 30, 2025 — BridgeBio Oncology Therapeutics, Inc. (BBOT) announced two poster presentations at...
Wave Life Sciences’ RNA Breakthrough Targets Obesity and Liver Disorders
BOSTON, October 29, 2025 — Wave Life Sciences Ltd. (NASDAQ: WVE), a clinical-stage biotechnology leader in RNA medicines, has...
Advertisement
